Advertisement

Isolated Systolic Hypertension

  • Syamkumar M. Divakara MenonEmail author
Chapter
First Online:
  • 1.2k Downloads

Abstract

  • ISH is diagnosed when systolic blood pressure is more than 140 mmHg with a normal or low diastolic pressure (less than 90 mmHg).

  • Prevalence of ISH increases with age, and it is one of the special problems in hypertension among geriatric population.

  • Contrary to traditional thinking, systolic hypertension is a strong predictor of cardiovascular morbidity and mortality.

  • Increased arterial stiffness resulting in augmented reflection of the pulse wave is the major pathophysiological mechanism in ISH along with functional changes like endothelial dysfunction, enhanced sympathetic tone, and abnormal sodium hemostasis.

  • Management of ISH can be a challenge, and drugs which reduce the augmentation index play a pivotal role in refractory cases.

This is a preview of subscription content, log in to check access.

References

  1. 1.
    Fletcher AE, Bulpitt CJ. Isolated systolic hypertension in the elderly. Cardiovasc Risk Factors. 1992;2:133–9.Google Scholar
  2. 2.
    Whelton PK, Jiang HE, Klag MJ. Blood pressure in westernized populations. In: Swales JD, editor. Textbook of hypertension. Blackwell Scientific Publications: London; 1994. p. 11–21.Google Scholar
  3. 3.
    Khder Y, Des Boscs LB, Aliot E, Zannad F. Endothelial, viscoelastic and sympathetic factors contributing to the arterial wall changes during ageing. Cardiol Elder. 1996;4:161–5.Google Scholar
  4. 4.
    Salvetti A, Ghaidoni L, Gennari A, Taddei S. Age influence on some aspects of cardiovascular adaptation to hypertension. High Blood Pressure. 1995;4:87–96.Google Scholar
  5. 5.
    Vanhoutte PM. Aging and vascular responsiveness. J Cardiovasc Pharmacol. 1988;12(Suppl 8):S11–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Fantini F, et al. Parallel increase in carotid, brachial and left ventricular cross-sectional areas in arterial hypertension. J Hum Hypertens. 1997;11:515–21.CrossRefPubMedGoogle Scholar
  7. 7.
    Gariepy J, et al. Echographic assessment of carotid and femoral arterial structure in men with essential hypertension. Am J Hypertens. 1996;9:126–36.CrossRefPubMedGoogle Scholar
  8. 8.
    O’Rourke MF, Kelly RP. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens. 1993;11:327–37.CrossRefPubMedGoogle Scholar
  9. 9.
    Schiffrin EL. Vascular stiffening and arterial compliance. Implications for systolic blood pressure. Am J Hypertens. 2004;17:39S–48.CrossRefPubMedGoogle Scholar
  10. 10.
    Society of Actuaries. Build and Blood pressure study, vol. 1. Chicago: Society of Actuaries; 1959. p. 268.Google Scholar
  11. 11.
    Wilkinson IB, Hall IR, MacCallum H, et al. Pulse-wave analysis. Clinical evaluation of a non-invasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol. 2002;22:147–52.CrossRefPubMedGoogle Scholar
  12. 12.
    Cohn JN. Vascular wall function as a risk marker for cardiovascular disease. J Hypertens. 1999;17(Suppl 5):S41–4.Google Scholar
  13. 13.
    Stokes GS. Nitrates as adjunct hypertensive treatment. Curr Hypertens Rep. 2006;8:60–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Stokes GS, Barin ES, Gilfillan KL. Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension. Hypertension. 2003;41:297–301.CrossRefPubMedGoogle Scholar
  15. 15.
    Weinberger MH, Miller JZ, Luft FC, et al. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8:127–34.CrossRefGoogle Scholar
  16. 16.
    Bagrov AY, Lakatta EG. The dietary sodium-blood pressure plot “stiffens”. Hypertension. 2004;44:22–4.CrossRefPubMedGoogle Scholar
  17. 17.
    Silagy CA, McNeil JJ. Epidemiologic aspects of isolated systolic hypertension and implications for future research. Am J Cardiol. 1992;69:213–8.CrossRefPubMedGoogle Scholar
  18. 18.
    The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413–46.Google Scholar
  19. 19.
    Rowe JW, Troen BR. Sympathetic nervous system and aging in man. Endocr Rev. 1980;12:167–79.CrossRefGoogle Scholar
  20. 20.
    WHO/ISH Guidelines Subcommittee. 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens. 1993;11:905–18.CrossRefGoogle Scholar
  21. 21.
    Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA. 1982;248:1465–77.CrossRefGoogle Scholar
  22. 22.
    Curb JD, et al. Isolated systolic hypertension in 14 communities. Am J Epidemiol. 1985;121:362–70.CrossRefPubMedGoogle Scholar
  23. 23.
    Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham Study. Circulation. 1980;61:1179–82.CrossRefPubMedGoogle Scholar
  24. 24.
    Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. Br Med J. 1992;304:405–12.Google Scholar
  26. 26.
    SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255–64.CrossRefGoogle Scholar
  27. 27.
    Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens. 1990;8:393–405.CrossRefPubMedGoogle Scholar
  28. 28.
    Townsend MS, Fulgoni VL III, Stern JS, et al. Low mineral intake is associated with high systolic blood pressure in the Third and Fourth National Health and Nutrition Examination Surveys. Could we all be right? Am J Hypertens. 2005;18:261–9.CrossRefPubMedGoogle Scholar
  29. 29.
    He FJ, Markandu ND, MacGregor GA. Modest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertension. Hypertension. 2005;46:66–70.CrossRefPubMedGoogle Scholar
  30. 30.
    Gates PE, Tanaka H, Hiatt WR, Seals DR. Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension. 2004;44:35–41.CrossRefPubMedGoogle Scholar
  31. 31.
    Brennan P, Pescatello LS, Bohannon RW, et al. Time spent moving is related to systolic blood pressure among older women. Prev Cardiol. 2005;8:160–4.CrossRefPubMedGoogle Scholar
  32. 32.
    Ferrier KE, Waddell TK, Gatzka CD, et al. Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension. Hypertension. 2001;38:222–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Chen C-H, Ting C-T, Lin S-J, et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension. 1995;25:1034–41.CrossRefPubMedGoogle Scholar
  34. 34.
    TO M, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17:118–23.CrossRefGoogle Scholar
  35. 35.
    The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288:2981–97.CrossRefGoogle Scholar
  36. 36.
    London G, Schmieder R, Calvo C, Asmar R. IndapamideSR versus candesartan and amlodipine in hypertension: the X-CELLENT Study. Am J Hypertens. 2006;19:113–21.CrossRefPubMedGoogle Scholar
  37. 37.
    Kostis JB, Wilson AC, Freudenberger RS, et al. Long term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. SHEP Collaborative Research Group. Am J Cardiol. 2005;95:29–35.CrossRefPubMedGoogle Scholar
  38. 38.
    Turnbull F, Blood Pressure Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials. Lancet. 2003;362:1527–153.CrossRefPubMedGoogle Scholar
  39. 39.
    Kjeldsen SE, Lyle PA, Kizer JR, et al. The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study. J Clin Hypertens. 2005;7:152–8.CrossRefGoogle Scholar
  40. 40.
    Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895–906.CrossRefPubMedGoogle Scholar

Copyright information

© The Editor(s)  2018

Authors and Affiliations

  1. 1.Cardiology, Cardiac Electrophysiology, Health EducationMcMaster UniversityHamiltonCanada

Personalised recommendations

Cite chapter

Buy options